Leaflet SULFAT DE ATROPINA TAKEDA 1mg / ml solution for injection

Indicated for: bradycardia; antidote in cholinergic poisoning

Route of administration: injectable

Substance: atropine (mydriatic)

ATC: A03BA01 (Alimentary tract and metabolism | Belladonna and derivatives, plain | Belladonna alkaloids, tertiary amines)

Precautions:
Glaucoma warning
Glaucoma warning

Use caution if you have glaucoma or increased eye pressure.

Anticholinergic effects
Anticholinergic effects

May cause dry mouth, constipation, urinary retention, or blurred vision.

Elderly warning
Elderly warning

Older people may have an increased risk of side effects.

Atropine is an anticholinergic medication used for various medical purposes, including the treatment of cardiac, ophthalmologic, and gastrointestinal conditions. It works by blocking muscarinic acetylcholine receptors, leading to smooth muscle relaxation, increased heart rate, and reduced secretions.

It is used to treat bradycardia (slow heart rate), poisoning with organophosphates or other cholinergic substances, to dilate the pupil for ophthalmic diagnostic purposes, and to reduce gastrointestinal spasms.

Atropine is administered as intravenous, intramuscular, or subcutaneous injections, and it is also available as ophthalmic drops.

Side effects may include dry mouth, blurred vision, constipation, urinary retention, tachycardia, and, in rare cases, confusion or hallucinations. It is contraindicated in patients with closed-angle glaucoma, severe prostatic hypertrophy, or gastrointestinal obstructions.

General data about SULFAT DE ATROPINA TAKEDA 1mg / ml

  • Substance: atropine
  • Date of latest medicines list: 01-06-2026
  • Product code: W60351002
  • Concentration: 1mg / ml
  • Pharmaceutical form: solution for injection
  • Packing volume: 1 ml
  • Product type: Generic medicine
  • Price: 72.55 RON
  • Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

  • Manufacturer: TAKEDA AUSTRIA GmbH - AUSTRIA
  • Holder: TAKEDA GmbH - GERMANIA
  • Number: 6061/2013/01
  • Shelf life: 2 years

Pharmaceutical forms available for atropine

Concentrations available for atropine

  • 0.1mg/ml
  • 1mg/ml

Compensation lists for SULFAT DE ATROPINA TAKEDA 1mg / ml Takeda

C3 - Sublist C - section C3 (children, pregnant women and postpartum women) with 100% discount from the reference price

Price

Copayment

Patient

72.55 RON

72.55 RON

0.00 RON